The T-Cell Chemokine Receptor CXCR3 Is Expressed Highly in Low-Grade Mycosis Fungoides

American Journal of Clinical Pathology

Volumn 115, Issue 3, 2001, Pages 413-421

  Lu, Di ^a   Duvic, Madeleine ^a   Medeiros, L Jeffrey ^a   Luthra, Rajyalakshmi ^a   Dorfman, David M ^b   Jones, Dan ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chemokine receptor; Cutaneous T cell lymphoma; G coupled proteins; Skin cancer; T cell lymphoma

Indexed keywords

CD30 ANTIGEN; CHEMOKINE RECEPTOR; CTAGE1 PROTEIN, HUMAN; CXC CHEMOKINE RECEPTOR 3; MEMBRANE PROTEIN; TUMOR ANTIGEN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CHEMISTRY; CHILD; COMPARATIVE STUDY; FEMALE; GENE REARRANGEMENT; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; PATHOLOGY; PROGNOSIS; SKIN TUMOR; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD30; ANTIGENS, NEOPLASM; BIOPSY; CHILD; FEMALE; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MYCOSIS FUNGOIDES; PROGNOSIS; RECEPTORS, CHEMOKINE; SKIN NEOPLASMS; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 0035286152     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/3N7P-J84L-JQ9K-G89R     Document Type: Article

References (34)

1. Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): a review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol. 1994; 18:645-667.
2. Salhany KE, Cousar JB, Greer JP, et al. Transformation of cutaneous T cell lymphoma to large cell lymphoma: a clinicopathologic and immunologic study. Am J Pathol. 1988;132:265-277.
3. Greer JP, Salhany KE, Cousar JB, et al. Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process. Hematol Oncol. 1990;8:215-227.
4. Lee BN, Duvic M, Tang CK, et al. Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma. Clin Diagn Lab Immunol. 1999;6:79-84.
5. Vermeer MH, Geelen FA, Kummer JA, et al. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Am J Pathol. 1999;154:1203-1210.
6. Navas IC, Ortiz-Romero PL, Villuendas R, et al. p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol. 2000;156:1565-1572.
7. Li G, Chooback L, Wolfe JT, et al. Overexpression of p53 protein in cutaneous T cell lymphoma: relationship to large cell transformation and disease progression. J Invest Dermatol. 1998;110:767-770.
8. Sarris AH, Esgleyes-Ribot T, Crow M, et al. Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma? Blood. 1995;86:651-658.
9. Tensen CP, Vermeer MH, van der Stoop PM, et al. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas. J Invest Dermatol. 1998;111:222-226.
10. Flier J, Boorsma DM, Bruynzeel DP, et al. The CXCR3 activating chemokines IP-10, Mig, and IP-9 are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol. 1999;113:574-578.
11. Tensen CP, Flier J, Van Der Raaij-Helmer EM, et al. Human IP-9: a keratinocyte-derived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol. 1999;112:716-722.
12. Sallusto F, Lenig D, Mackay CR, et al. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998;187:875-883.
13. Jones D, O'Hara C, Kraus M, et al. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma. Blood. 2000;96:685-690.
14. Diamandidou E, Colome-Grimmer M, Fayad L, et al. Transformation of mycosis fungoides/Sézary syndrome: clinical characteristics and prognosis. Blood. 1998;92:1150-1159.
15. Qin S, Rottman JB, Myers P, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest. 1998;101:746-754.
16. Trentin L, Agostini C, Facco M, et al. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest. 1999;104:115-121.
17. Jones D, Benjamin RJ, Shahsafaei A, et al. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood. 2000;95:627-632.
18. Theodorou I, Delfau-Larue MH, Bigorgne C, et al. Cutaneous T-cell infiltrates: analysis of T-cell receptor gamma gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis. Blood. 1995;86:305-310.
19. Luster AD, Ravetch JV. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10). J Exp Med. 1987;166:1084-1097.
20. Boorsma DM, Flier J, van den Brink EN, et al. IP-10 mRNA expression in cultured keratinocytes is suppressed by inhibition of protein kinase-C and tyrosine kinase and elevation of cAMP. Cytokine. 1999;11:469-475.
21. Sarris AH, Daliani D, Ulmer R, et al. Interferon-inducible protein 10 as a possible factor in the pathogenesis of cutaneous T-cell lymphomas. Clin Cancer Res. 1997;3:169-177.
22. Sarris AH, Daliani D, Ulmer R, et al. Interferon-inducible protein-10 and the pathogenesis of cutaneous T-cell lymphomas. Leuk Lymphoma. 1996;24:103-110.
23. Noorduyn LA, Beljaards RC, Pals ST, et al. Differential expression of the HECA-452 antigen (cutaneous lymphocyte associated antigen, CLA) in cutaneous and non-cutaneous T-cell lymphomas. Histopathology. 1992;21:59-64.
24. Kadin, ME. Lymphomatoid papulosis, Ki-1+ lymphoma, and primary cutaneous Hodgkin's disease. Semin Dermatol. 1991;10:164-171.
25. Morales J, Homey B, Vicari AP, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells. Proc Natl Acad Sci U S A. 1999;96:14470-14475.
26. Hromas R, Broxmeyer HE, Kim C, et al. Isolation of ALP, a novel divergent murine CC chemokine with a unique carboxy terminal extension. Biochem Biophys Res Commun. 1999; 258:737-740.
27. Ishikawa-Mochizuki I, Kitaura M, Baba M, et al. Molecular cloning of a novel CC chemokine, interleukin-11 receptor alpha-locus chemokine (ILC), which is located on chromosome 9p13 and a potential homologue of a CC chemokine encoded by molluscum contagiosum virus. FEBS Lett. 1999;460:544-548.
28. Gosling J, Dairaghi DJ, Wang Y, et al. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J Immunol. 2000;164:2851-2856.
29. Bonini JA, Martin SK, Dralyuk F, et al. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell Biol. 1997;16:1249-1256.
30. Baird JW, Nibbs RJ, Komai-Koma M, et al. ESkine, a novel beta-chemokine, is differentially spliced to produce secretable and nuclear targeted isoforms. J Biol Chem. 1999;274:33496-33503.
31. Homey B, Wang W, Soto H, et al. Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol. 2000;164:3465-3470.
32. Campbell JJ, Haraldsen G, Pan J, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 1999;400:776-780.
33. Marti RM, Hausmann G, Estrach T, et al. T-cell population of primary and secondary cutaneous B-cell lymphomas does not express the cutaneous lymphocyte-associated antigen (CLA). Arch Dermatol Res. 1997;289:327-330.
34. Jones D, Weissmann D, Kraus M, et al. Recurrences in nodal T-cell lymphoma: changes in histologic appearance and immunophenotype over the course of disease. Am J Clin Pathol. 2000;114:438-447.